Comparison of the serum level of interleukin‐4 in patients with brucellosis and healthy controls

Evaluation of cytokines such as interleukin‐4 (IL‐4) can be an important tool in examining immune responses to brucellosis. Also, determining the response rate to treatment is necessary for controlling and eradicating of disease. The review of previous studies reveals contradictory results that require further research in this regard. The aim of this study was to compare the serum level of IL‐4 in patients with brucellosis and healthy controls.

[1]  A. Shamshiri,et al.  Cytokine Profiles in Acute Brucellosis, Compared with Those in Other Febrile Illnesses , 2017 .

[2]  M. A. Reza,et al.  Serum interferon-gamma and interleukin-4 in patients with brucellosis before and after treatment , 2017 .

[3]  Zaheer Ul-Haq,et al.  Interleukin-4 receptor signaling and its binding mechanism: A therapeutic insight from inhibitors tool box. , 2016, Cytokine & growth factor reviews.

[4]  M. Shalayel,et al.  Correlation of interleukin-4 levels with Plasmodium falciparum malaria parasitaemia in Sudanese children , 2015, Acta clinica Belgica.

[5]  L. Xia,et al.  Interleukin-4 in rheumatoid arthritis patients with interstitial lung disease: a pilot study , 2013, The Indian journal of medical research.

[6]  Ramezani Amitis,et al.  DIFFERENTIATION OF BRUCELLA-INDUCED EPIDIDYMO-ORCHITIS FROM NONSPECIFIC EPIDIDYMO-ORCHITIS IN AN ENDEMIC AREA FOR BRUCELLOSIS , 2013 .

[7]  E. Eskandari-Nasab,et al.  Relationship between γ‐interferon gene polymorphisms and susceptibility to brucellosis infection , 2013, Microbiology and immunology.

[8]  H. Akbari,et al.  Relationship between serum levels of IL-4 and IgE with disease severity in allergic asthma , 2013 .

[9]  E. Eskandari-Nasab,et al.  Levels of Interleukin‐(IL)‐12p40 are Markedly Increased in Brucellosis Among Patients with Specific IL‐12B Genotypes , 2013, Scandinavian journal of immunology.

[10]  R. Locksley,et al.  Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. , 2013, Annual review of immunology.

[11]  A. Moravej,et al.  Interleukin-17A genetic variants can confer resistance to brucellosis in Iranian population. , 2013, Cytokine.

[12]  J. Gorvel,et al.  Internal affairs: investigating the Brucella intracellular lifestyle. , 2012, FEMS microbiology reviews.

[13]  S. Farahani,et al.  An investigation of the epidemiology of brucellosis in Arak City, Iran, (2001-2010) , 2012 .

[14]  S. Bodhankar,et al.  Interferon gamma and interleukin 4 have contrasting effects on immunopathology and the development of protective adaptive immunity against mycoplasma respiratory disease. , 2010, The Journal of infectious diseases.

[15]  M. Eisenhut.  The role of interleukin‐4 in the immune response to Plasmodium falciparum , 2010, Parasite immunology.

[16]  I. Baydar,et al.  TNF-α, TGF-β, IL-10, IL-6 and IFN-γ gene polymorphisms as risk factors for brucellosis , 2009 .

[17]  I. Baydar,et al.  TNF-alpha, TGF-beta, IL-10, IL-6 and IFN-gamma gene polymorphisms as risk factors for brucellosis. , 2009, The new microbiologica.

[18]  A. Velayati,et al.  Risk factors for human brucellosis in Iran: a case-control study. , 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[19]  A. Kariminia,et al.  Dominant Th1 cytokine production in early onset of human brucellosis followed by switching towards Th2 along prolongation of disease. , 2006, The Journal of infection.

[20]  V. Bulut,et al.  Determination of intracellular cytokines produced by Th1 and Th2 cells using flow cytometry in patients with brucellosis. , 2005, FEMS immunology and medical microbiology.

[21]  A. Kalkan,et al.  Serum cytokine levels in patients with acute brucellosis and their relation to the traditional inflammatory markers. , 2003, FEMS immunology and medical microbiology.

[22]  Javier Martín,et al.  Inducible nitric oxide synthase promoter polymorphism in human brucellosis. , 2003, Microbes and infection.

[23]  K. Bourantas,et al.  Interleukin-3 and Interleukin-4 in Childhood Brucellosis , 2002, Infection.

[24]  K. Oishi,et al.  Increased serum levels of interferon-gamma and interleukin-12 during human brucellosis. , 1999, The American journal of tropical medicine and hygiene.

[25]  A. Kelso,et al.  Differential activation of Brucella-reactive CD4+ T cells by Brucella infection or immunization with antigenic extracts , 1995, Infection and immunity.